Medicine
Letairis 5 mg tablet
Letairis 5 mg tablet is a prescription medicine containing Ambrisentan for oral use, marketed by Gilead Sciences, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25° C (77° F), excursions permitted to 15 – 30° C (59 – 86° F). Store…
Key facts
- Active ingredient (INN)
- Ambrisentan
- Brand
- Letairis
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 3 blister pack, 1 blister pack and 3 more
- Marketing authorisation holder
- Gilead Sciences
- Manufacturer
- Gilead Sciences
- Origin register
- US FDA, United States
- Storage
- Store at 25° C (77° F), excursions permitted to 15 – 30° C (59 – 86° F). Store Letairis in its original packaging.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C02KX02 Ambrisentan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 June 2007
- Identifiers
- RxCUI 722116, 722120, 722122 +1DailyMed set ID 725d4e73-6c83-477a-adc6-0ae4a133a844NDC 61958-0801Application NDA022081
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle, plastic | 61958-0801-1 | Gilead Sciences | 15 June 2007 |
| 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 61958-0801-2 | Gilead Sciences | 15 June 2007 |
| 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 61958-0801-3 | Gilead Sciences | 15 June 2007 |
| 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 61958-0801-4 | Gilead Sciences | 15 June 2007 |
| 10 tablet, film coated in 1 bottle, plastic | 61958-0801-5 | Gilead Sciences | 15 June 2007 |
| 10 tablet, film coated in 1 bottle, plastic | 61958-0801-6 | Gilead Sciences | 15 June 2007 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ambrisentan 5 mg tablet.
Other strengths and forms of Ambrisentan
Clinical summary
Ambrisentan is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients. It is available as tablets for oral use. MedsAcross supplies Ambrisentan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AmbrisentanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Letairis prescribing information (Gilead Sciences) · U.S. National Library of Medicine, DailyMed
- Volibris: European public assessment report (EPAR) · European Medicines Agency
- Ambrisentan Viatris (previously Ambrisentan Mylan): European public assessment report (EPAR) · European Medicines Agency
Need Letairis 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.